Markets:

Overview

News

Currencies

International

Treasuries

Ainos, Inc. - Common Stock (NQ:AIMD)

1.580 +0.080 (+5.33%)

Streaming Delayed Price Updated: 4:00 PM EDT, May 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ainos, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Why Baudax Bio Shares Are Trading Higher By 60%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 24, 2023

Gainers Baudax Bio, Inc. (NASDAQ: BXRX) shares surged 59.7% to $5.03 after the company announced the outcome of its first interim analysis in a Phase II trial of BX1000 for neuromuscular blockade in...

Via Benzinga

Ainos and Tah-An Sign MoU to Explore Manufacture of VELDONA Animal Investigational New Drug

January 23, 2023

Via ACCESSWIRE

Ainos Issues 2023 Shareholder Letter

January 17, 2023

Via ACCESSWIRE

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

December 01, 2022

Via Benzinga

Why Dollar General Shares Are Trading Lower By Over 8%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session ↗

December 01, 2022

Gainers Top Ships Inc. (NASDAQ: TOPS) shares jumped 74% to $5.24. Vapotherm, Inc. (NASDAQ: VAPO) gained 48.8% to $1.3250.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 29, 2022

Via Benzinga

Why Shares Of Chinese Companies Are Trading Higher? Here Are 45 Stocks Moving In Tuesday's Mid-Day Session ↗

November 29, 2022

Gainers Otonomy, Inc. (NASDAQ: OTIC) shares surged 74.2% to $0.1866. Otonomy recently posted a Q3 loss of $0.18 per share.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 24, 2022

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

November 18, 2022

Via Benzinga

Ainos Pursues Licensing Partners to Accelerate Five Candidates of its Low-dose Oral Interferon Formulation VELDONA to Phase 3 Trials and Commercialization

October 31, 2022

Via ACCESSWIRE

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 03, 2022

Gainers LogicBio Therapeutics (NASDAQ:LOGC) shares moved upwards by 641.3% to $2.02 during Monday's pre-market session. The company's market cap stands at $66.5 million.

Via Benzinga

Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Friday ↗

October 03, 2022

Gainers FingerMotion, Inc. (NASDAQ: FNGR) gained 82.2% to close at $3.37.

Via Benzinga

Dow Tumbles Over 300 Points; Crude Oil Down 2% ↗

September 30, 2022

U.S. stocks traded lower toward the end of trading, with the Dow Jones dipping more than 300 points on Friday.

Via Benzinga

Stocks Struggle For Direction As Choppy Q3 Comes To An End ↗

September 30, 2022

Markets are having a hard time deciding how to end a dismal week (and month, and quarter).

Via Talk Markets

FUV Stock Alert: What Is Going on With Arcimoto Today? ↗

September 30, 2022

Arcimoto (FUV) stock is on a wild ride today after the electric vehicle (EV) company revealed plans for a strategic restructuring.

Via InvestorPlace

Why Is Ainos (AIMD) Stock Skyrocketing Today? ↗

September 30, 2022

Ainos (AIMD) stock is gaining on Friday after seeing positive results from hamster clinical trials of its Covid-19 treatment.

Via InvestorPlace

Why Carnival Shares Are Trading Lower By 19%, Here Are 49 Stocks Moving In Friday's Mid-Day Session ↗

September 30, 2022

Gainers

Via Benzinga

Nasdaq Jumps Over 100 Points; Crude Oil Down 1.5% ↗

September 30, 2022

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 100 points on Friday.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 30, 2022

Gainers Ainos (NASDAQ:AIMD) shares increased by 46.4% to $2.02 during Friday's pre-market session. The market value of their outstanding shares is at $39.3 million.

Via Benzinga

Ainos Announces Positive Results from Additional Preclinical Study of Its Low-dose Oral Interferon Formulation Against New Variant Virus - Omicron

September 30, 2022

Via ACCESSWIRE

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 21, 2022

Gainers Scopus BioPharma (NASDAQ:SCPS) stock moved upwards by 10.9% to $0.3 during Wednesday's pre-market session. The market value of their outstanding shares is at $6.3 million.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 20, 2022

Gainers CinCor Pharma (NASDAQ:CINC) shares moved upwards by 19.5% to $33.0 during Tuesday's after-market session. The market value of their outstanding shares is at $1.4 billion.

Via Benzinga

Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday ↗

September 19, 2022

Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.

Via Benzinga

Why NCR Is Trading Lower By Around 23%, Here Are 42 Stocks Moving In Friday's Mid-Day Session ↗

September 16, 2022

Gainers Kensington Capital Acquisition Corp. IV (NYSE: AMPX) jumped 35.4% to $13.54 after gaining 11% on Thursday.

Via Benzinga

Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary ↗

August 24, 2022

Via Benzinga

Ainos Seeks FDA Nod For Mid-Stage Covid-19 Study ↗

August 24, 2022

Ainos, Inc. (NASDAQ: AIMD) has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration for conducting a Phase 2 trial of its drug candidate VELDONA, for...

Via Benzinga

Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday ↗

September 07, 2022

Gainers Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility.

Via Benzinga

Why Chimerix Is Trading Higher By Over 19%, Here Are 53 Stocks Moving In Monday's Mid-Day Session ↗

August 29, 2022

Gainers Advanced Human Imaging Limited (NASDAQ: AHI) shares jumped 53% to $1.04. Advanced Human Imaging announced Sunday it signed a Master Services Agreement with Estonia-based Activate Health OÜ.

Via Benzinga

Ainos Submits Investigational New Drug Application to the U.S. FDA to Conduct Phase 2 Trial of its VELDONA Low-dose Oral Interferon Formulation Against Mild COVID-19 Symptoms

August 24, 2022

Via ACCESSWIRE

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

August 18, 2022

It's time to take a look at the biggest pre-market stock movers for Thursday and the news that's got those shares moving!

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.